CYP4A22: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
CSV import
 
Line 22: Line 22:
{{cytochrome-stub}}
{{cytochrome-stub}}
{{No image}}
{{No image}}
__NOINDEX__

Latest revision as of 06:40, 17 March 2025

CYP4A22 is a member of the cytochrome P450 superfamily of enzymes. These enzymes are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids, and other lipids. The CYP4A22 gene is located on chromosome 1 in humans.

Function[edit]

CYP4A22 is involved in the metabolism of fatty acids. It primarily catalyzes the omega-hydroxylation of medium-chain fatty acids. This enzyme plays a role in the metabolism of arachidonic acid and other polyunsaturated fatty acids, contributing to the production of bioactive lipid mediators.

Gene[edit]

The CYP4A22 gene is part of the CYP4A subfamily, which includes other members such as CYP4A11, CYP4A12, and CYP4A14. These genes are clustered together on chromosome 1 and share a high degree of sequence similarity.

Expression[edit]

CYP4A22 is expressed in various tissues, including the liver, kidney, and heart. Its expression can be induced by certain chemicals, such as peroxisome proliferators, which are known to activate the peroxisome proliferator-activated receptor alpha (PPARα).

Clinical Significance[edit]

Mutations or polymorphisms in the CYP4A22 gene may affect the enzyme's function and have been associated with various diseases, including hypertension and metabolic syndrome. The enzyme's role in fatty acid metabolism also implicates it in conditions related to lipid metabolism disorders.

See Also[edit]

References[edit]

<references group="" responsive="1"></references>


External Links[edit]

Template:Cytochrome-stub